Last reviewed · How we verify
NCT07362108
Cardiovascular Events Related to Treated Coronary Arteries in Stable Multivessel CAD
trial testing Coronary Artery Bypass Grafting in Coronary Artery Disease in 1,695 participants. Completed in 31 December 2025.
31 December 2025
Quick facts
| Lead sponsor | Instituto do Coracao |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,695 |
| Start date | 1 January 1995 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
Drugs / interventions tested
- Coronary Artery Bypass Grafting
- Percutaneous Coronary Intervention
- Optimized Medical Therapy — full drug profile →
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Stable Coronary Artery Disease — all drugs for Stable Coronary Artery Disease →
- Multivessel Coronary Artery Disease — all drugs for Multivessel Coronary Artery Disease →
- Myocardial Ischemia — all drugs for Myocardial Ischemia →
Sponsor
Instituto do Coracao — full company profile →
Who can join
18 and older, any sex, with Coronary Artery Disease or Stable Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective cohort study evaluates cardiovascular events directly related to treated coronary arteries in patients with stable multivessel coronary artery disease. Outcomes in patients undergoing coronary artery bypass grafting or percutaneous coronary intervention will be compared with those receiving optimized medical therapy alone. This study aims to improve understanding of how different treatment strategies impact long-term vessel-related outcomes in patients with stable multivessel coronary artery disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07362108
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Coronary Artery Bypass Grafting
Trials testing the same drug.
- NCT07373678 — CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion · completed
- NCT03774342 — The Influence of Cognitive Decline on Quality of Life After Coronary Bypass · unknown
- NCT04639856 — ICU Stay in Patients With Low Ejection Fraction Undergoing Cardiac Revascularization: Comparison of On-pump vs Off-pump · NA · completed
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Instituto do Coracao trials
Trials by the same sponsor.
- NCT04313959 — Comparison Erect Spine in Cardiac Surgery · Phase 3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07362108 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto do Coracao
- Last refreshed: 23 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07362108.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing